You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molluscum Contagiosum

Showing 1 - 25 of 157
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Molluscum Contagiosum Trial in Abbottabad (Group A received cryotherpay, Group B received 10% Potassium Hydroxide Solution)

Completed
  • Molluscum Contagiosum
  • Group A received cryotherpay
  • Group B received 10% Potassium Hydroxide Solution
  • Abbottābād, Khyber Pakhtunkhwa, Pakistan
    CMH Abbottabad
May 31, 2023

Molluscum Contagiosum Trial in Abbottabad (potassium hydroxide)

Completed
  • Molluscum Contagiosum
  • potassium hydroxide
  • Abbottabad, KPK, Pakistan
    CMH
Nov 22, 2022

Molluscum Contagiosum Treated With5% Solution of Potassium

Not yet recruiting
  • Molluscum Contagiosum
    • Multiple Locations, France
      Multiple locations
    Dec 24, 2022

    Verruca Vulgaris, Molluscum Contagiosum Trial (Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma

    Not yet recruiting
    • Verruca Vulgaris
    • Molluscum Contagiosum
    • Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)
    • (no location specified)
    Jun 30, 2023

    Molluscum Contagiosum Trial in Oklahoma City (Benzoyl peroxide, Adapalene Gel)

    Not yet recruiting
    • Molluscum Contagiosum
    • Benzoyl peroxide
    • Adapalene Gel
    • Oklahoma City, Oklahoma
      OU Health Department of Dermatology
    Sep 7, 2022

    Molluscum Contagiosum Trial in Houston (Picato)

    Withdrawn
    • Molluscum Contagiosum
    • Houston, Texas
      Center for Clinical Studies
    Mar 21, 2022

    Verruca Vulgaris, Molluscum Contagiosum Skin Infection Trial in Charleston (Floating electrode-dielectric barrier device

    Recruiting
    • Verruca Vulgaris
    • Molluscum Contagiosum Skin Infection
    • Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)
    • +2 more
    • Charleston, South Carolina
      Medical University of South Carolina
    Mar 14, 2022

    Molluscum Contagiosum Trial in Lincoln (VP-102 with applicator)

    Completed
    Has Results
    • Molluscum Contagiosum
    • VP-102 with applicator
    • Lincoln, Nebraska
      Midwest Children's Health
    Aug 9, 2021

    Actinic Keratosis, Acne/Rosacea, Verruca Plana Trial in New City (Non-thermal, atmospheric plasma to treat skin lesions and

    Recruiting
    • Actinic Keratosis
    • +6 more
    • Non-thermal, atmospheric plasma to treat skin lesions and acne
    • Indirect non-thermal, atmospheric plasma to treat hair loss and acne
    • New City, New York
      The Skin Center Dermatology Group
    Apr 10, 2022

    Molluscum Contagiosum Trial in United States (SB206 10.3% berdazimer, vehicle gel)

    Completed
    Has Results
    • Molluscum Contagiosum
    • SB206 10.3% berdazimer
    • vehicle gel
    • Glendale, Arizona
    • +54 more
    Jan 1, 2023

    Molluscum Contagiosum Trial in United States (VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming

    Completed
    Has Results
    • Molluscum Contagiosum
    • VP-102 - Cantharidin, Topical Film Forming Solution
    • Placebo -Topical Film Forming Solution without VP-102
    • Bakersfield, California
    • +14 more
    Nov 15, 2021

    Molluscum Contagiosum Trial in United States (VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming

    Completed
    Has Results
    • Molluscum Contagiosum
    • VP-102 - Cantharidin, Topical Film Forming Solution
    • Placebo -Topical Film Forming Solution without VP-102
    • Birmingham, Alabama
    • +17 more
    Dec 21, 2021

    Molluscum Contagiosum Trial in United States (SB206 12%, Placebo)

    Completed
    • Molluscum Contagiosum
    • SB206 12%
    • Placebo
    • Mobile, Alabama
    • +34 more
    Mar 31, 2022

    Molluscum Contagiosum Trial in Assiut (Acyclovir, KOH 10 %)

    Unknown status
    • Molluscum Contagiosum
    • Assiut, New Assiut City, Egypt
      Hamdy Gomaa
    Jul 14, 2020

    Molluscum Contagiosum Trial in United States (SB206 4%, SB206 8%, SB206 12%)

    Completed
    • Molluscum Contagiosum
    • SB206 4%
    • +3 more
    • Scottsdale, Arizona
    • +17 more
    Oct 17, 2019

    Molluscum Contagiosum Trial in United States (SB206 12%, Placebo)

    Completed
    • Molluscum Contagiosum
    • SB206 12%
    • Placebo
    • Scottsdale, Arizona
    • +26 more
    Feb 14, 2020

    Molluscum Contagiosum Trial in San Antonio (10% East Indian sandalwood oil cream, Placebo Cream)

    Terminated
    • Molluscum Contagiosum
    • 10% East Indian sandalwood oil cream
    • Placebo Cream
    • San Antonio, Texas
      Texas Dermatology and Laser Specialists
    Apr 11, 2019

    Molluscum Contagiosum Trial in Bronx (Cantharidin)

    Completed
    Has Results
    • Molluscum Contagiosum
    • Bronx, New York
      Montefiore Medical Center
    Jan 10, 2019

    Erysipelas, Impetigo, Herpes Zoster Trial in Bergamo (Screening, Tele-dermatology)

    Completed
    • Erysipelas
    • +9 more
    • Screening
    • Tele-dermatology
    • Bergamo, Italy
      Local Health Authority (ATS)
    May 16, 2019

    Molluscum Contagiosum Trial in Fort Washington, Greenville, Mount Pleasant (VBP-245 Topical Gel, Vehicle)

    Completed
    • Molluscum Contagiosum
    • Fort Washington, Pennsylvania
    • +2 more
    Oct 9, 2018

    DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

    Recruiting
    • DOCK8 Deficiency
    • Reduced-intensity hematopoietic stem cell
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Inflammation; Skin, Resolution, Blister Trial in Boston (Lovaza, Cantharone, Phlebotomy)

    Completed
    • Inflammation; Skin
    • +2 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    May 25, 2022

    Atopic Dermatitis Trial in Hiroshima (0.3% OPA-15406 ointment, 1% OPA-15406 ointment)

    Completed
    Has Results
    • Atopic Dermatitis
    • 0.3% OPA-15406 ointment
    • 1% OPA-15406 ointment
    • Hiroshima, Japan
      Shirao clinic of pediatrics and pediatric allergy
    Oct 21, 2021

    Atopic Dermatitis Trial in Japan (Crisaborole 2%)

    Terminated
    Has Results
    • Atopic Dermatitis
    • Crisaborole 2%
    • Hiroshima-shi, Hiroshima, Japan
    • +10 more
    Jul 20, 2021

    HIV Prevention Trial in Worldwide (Placebo rectal insert, Placebo rectal suppository, Placebo rectal douche)

    Completed
    Has Results
    • HIV Prevention
    • Placebo rectal insert
    • +2 more
    • Birmingham, Alabama
    • +6 more
    Jan 4, 2023